The Role of Long Non-Coding RNA NNT-AS1 in Neoplastic Disease

Overview

Journal Cancers (Basel)

Publisher MDPI

Specialty Oncology

Date 2020 Oct 29

PMID 33113895

Citations 14

Authors

Cong Zhou

Shiwei Duan

Affiliations

Soon will be listed here.

Abstract

Studies have shown that non-coding RNAs (ncRNAs), especially long non-coding RNAs (lncRNAs), play an important regulatory role in the occurrence and development of human cancer. Nicotinamide nucleotide transhydrogenase-antisense 1 (NNT-AS1) is a newly-discovered cytoplasmic lncRNA. Many studies have shown that it has abnormally-high expression levels in malignant tumors, but there are also a few studies that have reported low expression levels of NNT-AS1 in gastric cancer, breast cancer, and ovarian cancer. At present, the regulatory mechanism of NNT-AS1 as a miRNA sponge, which may be an important reason affecting tumor cell proliferation, invasion, metastasis, and apoptosis is being studied in-depth. In addition, NNT-AS1 has been found to be related to cisplatin resistance. In this review, we summarize the abnormal expression of NNT-AS1 in a variety of neoplastic diseases and its diagnostic and prognostic value, and we explain the mechanism by which NNT-AS1 regulates cancer progression by competing with miRNAs. In addition, we also reveal the correlation between NNT-AS1 and cisplatin resistance and the potential clinical applications of NNT-AS1.

Citing Articles

Potential role of lncRNA LOXL1-AS1 in human cancer development: a narrative review.

Tang M, Rong Y, Liu S, Wu Z, Ma G, Li X Transl Cancer Res. 2024; 13(4):1997-2011.

PMID: 38737681 PMC: 11082674. DOI: 10.21037/tcr-23-1450.

Immunosuppression in liver transplant oncology: position paper of the Italian Board of Experts in Liver Transplantation (I-BELT).

Cillo U, Carraro A, Avolio A, Cescon M, Di Benedetto F, Giannelli V Updates Surg. 2024; 76(3):725-741.

PMID: 38713396 DOI: 10.1007/s13304-024-01845-z.

NNT-AS1 in CAFs-derived exosomes promotes progression and glucose metabolism through miR-889-3p/HIF-1α in pancreatic adenocarcinoma.

Zhang P, Wang Q, Lu W, Zhang F, Wu D, Sun J Sci Rep. 2024; 14(1):6979.

PMID: 38521881 PMC: 10960871. DOI: 10.1038/s41598-024-57769-6.

Long Non-Coding RNA LOC339059 Attenuates IL-6/STAT3-Signaling-Mediated PDL1 Expression and Macrophage M2 Polarization by Interacting with c-Myc in Gastric Cancer.

Han H, Ding G, Wang S, Meng J, Lv Y, Yang W Cancers (Basel). 2023; 15(22).

PMID: 38001573 PMC: 10670112. DOI: 10.3390/cancers15225313.

Unveiling the Genetic Complexity of Teratozoospermia: Integrated Genomic Analysis Reveals Novel Insights into lncRNAs' Role in Male Infertility.

Kyrgiafini M, Giannoulis T, Chatziparasidou A, Christoforidis N, Mamuris Z Int J Mol Sci. 2023; 24(19).

PMID: 37834450 PMC: 10573971. DOI: 10.3390/ijms241915002.

References

Li C, Zhang S, Qiu T, Wang Y, Ricketts D, Qi C . Upregulation of long non-coding RNA NNT-AS1 promotes osteosarcoma progression by inhibiting the tumor suppressive miR-320a. Cancer Biol Ther. 2018; 20(4):413-422. PMC: 6422455. DOI: 10.1080/15384047.2018.1538612. View

Djebali S, Davis C, Merkel A, Dobin A, Lassmann T, Mortazavi A . Landscape of transcription in human cells. Nature. 2012; 489(7414):101-8. PMC: 3684276. DOI: 10.1038/nature11233. View

Qiu J, Ye L, Ding J, Feng W, Zhang Y, Lv T . Effects of oestrogen on long noncoding RNA expression in oestrogen receptor alpha-positive ovarian cancer cells. J Steroid Biochem Mol Biol. 2014; 141:60-70. DOI: 10.1016/j.jsbmb.2013.12.017. View

Nelson B, Makarewich C, Anderson D, Winders B, Troupes C, Wu F . A peptide encoded by a transcript annotated as long noncoding RNA enhances SERCA activity in muscle. Science. 2016; 351(6270):271-5. PMC: 4892890. DOI: 10.1126/science.aad4076. View

Davaadelger B, Perez R, Zhou Y, Duan L, Gitelis S, Maki C . The IGF-1R/AKT pathway has opposing effects on Nutlin-3a-induced apoptosis. Cancer Biol Ther. 2017; 18(11):895-903. PMC: 5710671. DOI: 10.1080/15384047.2017.1345397. View

Chen Q, Wei C, Wang Z, Sun M . Long non-coding RNAs in anti-cancer drug resistance. Oncotarget. 2016; 8(1):1925-1936. PMC: 5352108. DOI: 10.18632/oncotarget.12461. View

De Luca A, Maiello M, DAlessio A, Pergameno M, Normanno N . The RAS/RAF/MEK/ERK and the PI3K/AKT signalling pathways: role in cancer pathogenesis and implications for therapeutic approaches. Expert Opin Ther Targets. 2012; 16 Suppl 2:S17-27. DOI: 10.1517/14728222.2011.639361. View

Gu Y, Zhu Z, Pei H, Xu D, Jiang Y, Zhang L . Long non-coding RNA NNT-AS1 promotes cholangiocarcinoma cells proliferation and epithelial-to-mesenchymal transition through down-regulating miR-203. Aging (Albany NY). 2020; 12(3):2333-2346. PMC: 7041725. DOI: 10.18632/aging.102747. View

Konermann S, Lotfy P, Brideau N, Oki J, Shokhirev M, Hsu P . Transcriptome Engineering with RNA-Targeting Type VI-D CRISPR Effectors. Cell. 2018; 173(3):665-676.e14. PMC: 5910255. DOI: 10.1016/j.cell.2018.02.033. View

10.

Li Y, Lv M, Song Z, Lou Z, Wang R, Zhuang M . Long non-coding RNA NNT-AS1 affects progression of breast cancer through miR-142-3p/ZEB1 axis. Biomed Pharmacother. 2018; 103:939-946. DOI: 10.1016/j.biopha.2018.04.087. View

11.

Stojic L, Lun A, Mangei J, Mascalchi P, Quarantotti V, Barr A . Specificity of RNAi, LNA and CRISPRi as loss-of-function methods in transcriptional analysis. Nucleic Acids Res. 2018; 46(12):5950-5966. PMC: 6093183. DOI: 10.1093/nar/gky437. View

12.

Chen B, Zhao Q, Guan L, Lv H, Bie L, Huang J . Long non-coding RNA NNT-AS1 sponges miR-424/E2F1 to promote the tumorigenesis and cell cycle progression of gastric cancer. J Cell Mol Med. 2018; 22(10):4751-4759. PMC: 6156444. DOI: 10.1111/jcmm.13726. View

13.

Liu Y, Guo R, Qiao Y, Han L, Liu M . LncRNA NNT-AS1 contributes to the cisplatin resistance of cervical cancer through NNT-AS1/miR-186/HMGB1 axis. Cancer Cell Int. 2020; 20:190. PMC: 7247171. DOI: 10.1186/s12935-020-01278-9. View

14.

Geary R, Norris D, Yu R, Bennett C . Pharmacokinetics, biodistribution and cell uptake of antisense oligonucleotides. Adv Drug Deliv Rev. 2015; 87:46-51. DOI: 10.1016/j.addr.2015.01.008. View

15.

Duchartre Y, Kim Y, Kahn M . The Wnt signaling pathway in cancer. Crit Rev Oncol Hematol. 2016; 99:141-9. PMC: 5853106. DOI: 10.1016/j.critrevonc.2015.12.005. View

16.

Liu Y, Wu G . NNT-AS1 enhances bladder cancer cell growth by targeting miR-1301-3p/PODXL axis and activating Wnt pathway. Neurourol Urodyn. 2019; 39(2):547-557. DOI: 10.1002/nau.24238. View

17.

Baran-Gale J, Purvis J, Sethupathy P . An integrative transcriptomics approach identifies miR-503 as a candidate master regulator of the estrogen response in MCF-7 breast cancer cells. RNA. 2016; 22(10):1592-603. PMC: 5029456. DOI: 10.1261/rna.056895.116. View

18.

Ren S, Liu Y, Xu W, Sun Y, Lu J, Wang F . Long noncoding RNA MALAT-1 is a new potential therapeutic target for castration resistant prostate cancer. J Urol. 2013; 190(6):2278-87. DOI: 10.1016/j.juro.2013.07.001. View

19.

Okazaki Y, Furuno M, Kasukawa T, Adachi J, Bono H, Kondo S . Analysis of the mouse transcriptome based on functional annotation of 60,770 full-length cDNAs. Nature. 2002; 420(6915):563-73. DOI: 10.1038/nature01266. View

20.

Fang Z, Zhao J, Xie W, Sun Q, Wang H, Qiao B . LncRNA UCA1 promotes proliferation and cisplatin resistance of oral squamous cell carcinoma by sunppressing miR-184 expression. Cancer Med. 2017; 6(12):2897-2908. PMC: 5727307. DOI: 10.1002/cam4.1253. View